InvestSMART

Microba Life Sciences Limited (ASX:MAP)

ALERT: Price-sensitive ASX Announcement for MAP
Current share price for MAP : $0.044 0.007 (18.92%)+
Announcement
Release
19 Jun 2026 9:09AM
Price at Release
$0.037
Full Release
download
Summary
Microba Life Sciences Limited is undertaking a capital raising effort via a Placement and a Securities Purchase Plan (SPP) to raise a total of $6.0 million before costs. The Placement involves issuing 100,004,240 New Shares at $0.05 with free-attaching New Options, aiming to raise $5.0 million. Concurrently, the SPP targets $1.0 million through issuing 20,000,000 New Shares, also at $0.05, with free-attaching New Options. New Options have an exercise price of $0.0625 and expire three years after issuance. A General Meeting on 24 July 2026 is scheduled to seek necessary Shareholder approvals. The company's pro forma balance sheet reflects growth in assets and equity from these initiatives. Key risk factors include regulatory, market, and competition risks, and the SPP Offer is subject to a potential scale-back if oversubscribed.
Key Points
  • Microba Life Sciences Limited is conducting a capital raising initiative consisting of a Placement and a Securities Purchase Plan (SPP).
  • The Placement aims to raise $5.0 million through the issue of 100,004,240 New Shares at $0.05 each, along with free-attaching New Options.
  • The SPP aims to raise an additional $1.0 million, offering 20,000,000 New Shares at $0.05 each, with free-attaching New Options.
  • New Options have an exercise price of $0.0625 and a three-year expiry.
  • A General Meeting is scheduled for 24 July 2026 for Shareholder approvals related to the Placement and SPP.
  • The pro forma balance sheet reflects increased assets and equity from these capital raising activities.
  • Key risks for investors include regulatory, market, competition, and operational risks.
  • The SPP Offer is not underwritten, and a scale-back may occur if oversubscribed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.